U.S. House · 117th Congress · H.R. 7828
PRICED Act
To amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 5 years.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Janice D. SchakowskyD-IL-9
- Introduced
- May 18, 2022, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (10)
9 Democrats, 1 Republican. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Rosa L. DeLauroD-CT-3
- Lloyd DoggettD-TX-35
- Jesús G. "Chuy" GarcíaD-IL-4
- Marcy KapturD-OH-9
- Ro KhannaD-CA-17
- Mark PocanD-WI-2
- Bruce WestermanR-AR-4
Signed on later
- Raja KrishnamoorthiD-IL-8May 24, 2022
- Pramila JayapalD-WA-7July 12, 2022
- Andy LevinD-MI-9July 12, 2022